We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.19%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.19%
10 Year Est. Return
–
AUM
$111M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow
% of AUM
97.8%
Top 10 Holdings %
Top 10 Hldgs %
35.94%
Holding
105
New
105
Increased
–
Reduced
–
Closed
–
Avg Time Held
11.3
quarters
Top 10 Avg Time Held
3.4
quarters
Top 20 Avg Time Held
4.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novo Nordisk
NVO
|
+$6.57M |
| 2 |
Data I/O
DAIO
|
+$5.31M |
| 3 |
Amazon
AMZN
|
+$4.95M |
| 4 |
ESIO
Electro Scientific Industries
ESIO
|
+$4.42M |
| 5 |
Microsoft
MSFT
|
+$4.25M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.95% |
| 2 | Healthcare | 12.85% |
| 3 | Energy | 10.8% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 9.17% |
Similar funds
AFW
QGA
AWA
BGAI
AIG
MFG
BCM
MCM
Penbrook Management's Q4 2017 Portfolio in Review
As of Q4 2017, Penbrook Management held 105 positions worth $111M. Its ten largest holdings account for 36% of the portfolio.
Penbrook Management deployed $109M of net new capital in Q4 2017, opening 105 new positions. Its largest new stake was Novo Nordisk: 258,200 shares worth $6.93M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, followed by Healthcare and Energy.
- Penbrook Management's largest Q4 2017 buy was Novo Nordisk: 258,200 shares worth $6.93M.
- Penbrook Management's ten largest holdings make up 36% of its $111M portfolio in Q4 2017.
- Penbrook Management opened 105 new positions and closed 0 in Q4 2017.
Based on Penbrook Management's 13F filing for Q4 2017, filed 21 Feb 2018.